Clinically advanced and metastatic pure mucinous carcinoma of the breast: a comprehensive genomic profiling study
- 13 January 2016
- journal article
- Published by Springer Science and Business Media LLC in Breast Cancer Research and Treatment
- Vol. 155 (2), 405-413
- https://doi.org/10.1007/s10549-016-3682-6
Abstract
No abstract availableKeywords
This publication has 58 references indexed in Scilit:
- Pure mucinous carcinoma of the breast: clinicopathologic characteristics and long-term outcome among Taiwanese womenWorld Journal of Surgical Oncology, 2013
- Comprehensive molecular portraits of human breast tumoursNature, 2012
- Everolimus in Postmenopausal Hormone-Receptor–Positive Advanced Breast CancerThe New England Journal of Medicine, 2012
- Pertuzumab plus Trastuzumab plus Docetaxel for Metastatic Breast CancerThe New England Journal of Medicine, 2012
- MK-1775, a Novel Wee1 Kinase Inhibitor, Radiosensitizes p53-Defective Human Tumor CellsClinical Cancer Research, 2011
- PI3K pathway activation results in low efficacy of both trastuzumab and lapatinibBMC Cancer, 2011
- PIK3CA Mutations in Patients with Advanced Cancers Treated with PI3K/AKT/mTOR Axis InhibitorsMolecular Cancer Therapeutics, 2011
- H1047R phosphatidylinositol 3-kinase mutant enhances HER2-mediated transformation by heregulin production and activation of HER3Oncogene, 2010
- FGFR1 Amplification Drives Endocrine Therapy Resistance and Is a Therapeutic Target in Breast CancerCancer Research, 2010
- FGFR1 amplification in breast carcinomas: a chromogenic in situhybridisation analysisBreast Cancer Research, 2007